Predictors of Response in Secukinumab-treated Patients with Ankylosing Spondylitis: Logistic Regression and Machine Learning Analyses

被引:0
|
作者
Miceli-Richard, Corinne [1 ]
Poddubnyy, Denis [2 ]
Deodhar, Atul [3 ]
Bao, Weibin [4 ]
Parman, Craig [5 ]
Porter, Brian [6 ]
Pournara, Effie [5 ]
机构
[1] Paris Descartes Univ, Hop Cochin, AP HP, Dept Rheumatol, Paris, France
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[4] Novartis Pharmaceut, East Hannover, NJ USA
[5] Novartis Pharma AG, Basel, Switzerland
[6] Novartis Pharmaceut, E Hanover, NJ USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1893
引用
收藏
页数:2
相关论文
共 50 条
  • [1] The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis
    van de Kerkhof, P. C. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (05) : 879 - 879
  • [2] Incidence of Uveitis in Secukinumab-treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies
    Deodhar, Atul A.
    Miceli-Richard, Corine
    Baraliakos, Xenofon
    Marzo-Ortega, Helena
    Gladman, Dafna D.
    Blanco, Ricardo
    Das Gupta, Ayan
    Martin, Ruvie
    Safi, Jorge
    Porter, Brian
    Shete, Abhijit
    Rosenbaum, James T.
    ACR OPEN RHEUMATOLOGY, 2020, 2 (05) : 294 - 299
  • [3] Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab
    Lorenzin, Mariagrazia
    Ortolan, Augusta
    Frallonardo, Paola
    Oliviero, Francesca
    Punzi, Leonardo
    Ramonda, Roberta
    BMC MUSCULOSKELETAL DISORDERS, 2015, 16
  • [4] Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab
    Mariagrazia Lorenzin
    Augusta Ortolan
    Paola Frallonardo
    Francesca Oliviero
    Leonardo Punzi
    Roberta Ramonda
    BMC Musculoskeletal Disorders, 16
  • [5] Symptoms of Peripheral Arthritis Are Significantly Improved in Patients with Ankylosing Spondylitis Treated with Secukinumab
    Mease, Philip
    Deodhar, Atul
    Calheiros, Renato
    Meng, Xiangyi
    Fox, Todd
    Baraliakos, Xenofon
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [6] SYMPTOMS OF PERIPHERAL ARTHRITIS ARE SIGNIFICANTLY IMPROVED IN PATIENTS WITH ANKYLOSING SPONDYLITIS TREATED WITH SECUKINUMAB
    Mease, P. J.
    Deodhar, A.
    Calheiros, R.
    Meng, X.
    Fox, T.
    Baraliakos, X.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 430 - 431
  • [7] Low Incidence of Both New-Onset and Flares of Uveitis in Secukinumab-Treated Patients with Ankylosing Spondylitis: Clinical Trial and Post-Marketing Safety Analysis
    Deodhar, Atul A.
    Miceli-Richard, Corinne
    Baraliakos, Xenofon
    Marzo-Ortega, Helena
    Gladman, Dafna D.
    Martin, Ruvie
    Safi, Jorge
    Porter, Brian
    Shete, Abhijit
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [8] LOW INCIDENCE OF BOTH NEW-ONSET AND FLARES OF UVEITIS IN SECUKINUMAB-TREATED PATIENTS WITH ANKYLOSING SPONDYLITIS: CLINICAL TRIAL AND POST-MARKETING SAFETY ANALYSIS
    Deodhar, A.
    Miceli-Richard, C.
    Baraliakos, X.
    Marzo-Ortega, H.
    Gladman, D.
    Martin, R.
    Safi, J., Jr.
    Porter, B.
    Shete, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 999 - 999
  • [9] LOW INCIDENCE OF BOTH NEW-ONSET AND FLARES OF UVEITIS IN SECUKINUMAB-TREATED PATIENTS WITH ANKYLOSING SPONDYLITIS: CLINICAL TRIAL AND POST-MARKETING SAFETY ANALYSIS
    Marzo-Ortega, Helena
    Deodhar, Atul
    Miceli-Richard, Corinne
    Baraliakos, Xenofon
    Gladman, Dafna D.
    Martin, Ruvie
    Safi, Jorge
    Porter, Brian
    Shete, Abhijit
    RHEUMATOLOGY, 2019, 58 : 152 - 152
  • [10] Predictors of Response in Patients with Ankylosing Spondylitis Treated with Infliximab or Golimumab in a Real-World Setting
    Bessette, Louis
    Kapur, Suneil
    Zummer, Michel
    Starr, Michael
    Choquette, Denis
    Sheriff, Maqbool
    Olszynski, Wojciech
    Rampakakis, Emmanouil
    Psaradellis, Eliofotisti
    Osborne, Brendan
    Maslova, Karina
    Nantel, Francois
    Lehman, Allen
    Tkaczyk, Cathy
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1197 - 1197